Home enteral nutrition via gastrostomy in advanced head and neck cancer patients

Head & Neck ◽  
1990 ◽  
Vol 12 (2) ◽  
pp. 137-142 ◽  
Author(s):  
Antonio Carlos L. Campos ◽  
Michael Butters ◽  
Michael M. Meguid
Keyword(s):  
Head And Neck Cancer ◽  
Enteral Nutrition ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Advanced Head ◽  
Home Enteral Nutrition

scholarly journals Immunoenhanced enteral nutrition, effect on inflammatory markers in head and neck cancer patients

2004 ◽  
Vol 59 (1) ◽  
pp. 145-147 ◽  
Author(s):  
D A de Luis ◽  
M Arranz ◽  
R Aller ◽  
O Izaola ◽  
L Cuellar ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Enteral Nutrition ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Inflammatory Markers

Compliance and Outcomes in Locally Advanced Head and Neck Cancer Patients Treated with Alternating Chemoradiotherapy in Clinical Practice

2003 ◽  
Vol 89 (1) ◽  
pp. 20-25 ◽  
Author(s):  
Vittorio Franciosi ◽  
Marco Fumagalli ◽  
Luciana Biscari ◽  
Roberto Martinelli ◽  
Teore Ferri ◽  
...  
Keyword(s):  
Overall Survival ◽  
Head And Neck Cancer ◽  
Clinical Practice ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Locally Advanced ◽  
Hematologic Toxicity ◽  
Advanced Head ◽  
Grade 3

Background and Aims To evaluate the feasibility in clinical practice of alternating chemo-radiotherapy in locally advanced head and neck cancer patients. Patients and Methods From August 1993 to April 1998 at the Division of Medical Oncology of Parma, 48 consecutive patients were observed, and 38 (79%) started the Merlano chemo-radiotherapy. The characteristics of the patients were: males (32, 84%); median age, 57 years; PS <2 (32, 84%). The primary sites were the oropharynx (18, 47%), oral cavity (8, 21%), hypopharynx (7, 19%), larynx (5, 13%); stage IV disease was present in 29 (76%) patients. Twenty-five (66%) patients were married, and 24 (63%) resided outside of the city. Results The compliance was very low: 21 patients (55%) performed all the programmed cycles of chemotherapy, whereas only 5 patients (13%) performed the chemo-radiotherapy at full doses without any delay. The objective responses were 3 (8%) complete and 21 (55%) complete plus partial responses. Failures were 2 (5%) stable disease and 2 (5%) progressive disease, and the response was not assessable in 10 (26%). The median duration of the response was 8 months. The median overall survival and the time to progression were 18 and 13 months, respectively; the 5-year overall and relapse-free survival were 36% and 26%, respectively. Nine (24%) patients were still alive as of August 30, 2001, 8 (21%) of them without progression. Twenty-six patients (68%) died with a local-regional relapse. One patient (3%) died for a second cancer. Grade 3–4 hematologic toxicity was leukopenia (n = 25, 66%) and thrombocytopenia (n = 9, 24%); grade 3–4 non-hematologic toxicity was diarrhea (n = 3, 8%) and mucositis (n = 2, 5%). Two patients (5%) died for intestinal infarction and perforation possibly related to treatment. Conclusions Compliance to the chemo-radiotherapy was very poor. The response rate was lower than that reported in clinical trials, whereas overall survival was comparable. The alternating chemo-radiotherapy is a very complex treatment that cannot be easily applied in clinical practice; a careful selection of patients is mandatory not only considering oncologic and medical criteria, but also the level of awareness of the patient and his family.

scholarly journals A Randomized Preventive Rehabilitation Trial in Advanced Head and Neck Cancer Patients Treated with Chemoradiotherapy: Feasibility, Compliance, and Short-term Effects

Dysphagia ◽  
2010 ◽  
Vol 26 (2) ◽  
pp. 155-170 ◽  
Author(s):  
Lisette van der Molen ◽  
Maya A. van Rossum ◽  
Lori M. Burkhead ◽  
Ludi E. Smeele ◽  
Coen R. N. Rasch ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Advanced Head ◽  
Short Term ◽  
Short Term Effects

Elective gastrostomy, nutritional status and quality of life in advanced head and neck cancer patients receiving chemoradiotherapy

2009 ◽  
Vol 79 (10) ◽  
pp. 713-718 ◽  
Author(s):  
Randall P. Morton ◽  
Victoria L. Crowder ◽  
Robert Mawdsley ◽  
Esther Ong ◽  
Mark Izzard
Keyword(s):  
Quality Of Life ◽  
Head And Neck Cancer ◽  
Nutritional Status ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Advanced Head
Sign in / Sign up

Export Citation Format

Share Document